- Generic Name: Brentuximab Vedotin
- Strength: 50 mg
- Packing: Single Vial
Indian Pharma Network is able to source the Brentuximab Vedotin (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Adcetris® ?
Brentuximab Vedotin is Generic Name for the trade name drug Adcetris®.
Is Brentuximab approved by European Authorities?
Yes, It is approved in most of the countries in Europe.
What is the dosage form of Brentuximab?
Brentuximab is available as 50 mg/vial Single use-vial.
What are the storage conditions of Brentuximab Vedotin 50 mg?
Brentuximab Vedotin 50 mg has to be stored and transported at 2-8°C (36–46°F) in its original carton to be protected from light. Brentuximab Vedotin has to be specially handled and to be disposed of as per disposal procedure, as it is an antineoplastic product. It should be kept out of reach of children.
Is there any generic or biosimilar available for Brentuximab Vedotin 50 mg?
There is no generic or biosimilar available for Brentuximab Vedotin 50 mg anywhere in the world.
How much does Brentuximab vedotin cost in India?
You can call or WhatsApp +91-9650877511 or send mail to info@indianpharmanetwork.in to know the brentuximab vedotin cost.
What are the Highlights of prescribing information for Brentuximab vedotin?
Click Here to download full Brentuximab prescribing information.
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.